Robinson James A. Jr. 4/A
4/A · UroGen Pharma Ltd. · Filed Jul 28, 2023
Insider Transaction Report
Form 4/AAmended
Robinson James A. Jr.
Director
Transactions
- Award
Stock Option (right to buy)
2023-07-25+20,000→ 20,000 totalExercise: $8.84Exp: 2033-07-25→ Ordinary Shares (20,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option vest in equal quarterly installments over 12 months